Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis
Abstract
Theory of oxidative stress is suggested in the pathophysiology of schizophrenia. To determine the cause of impaired antioxidant defense system in schizophrenia, a meta-analysis was performed by selecting studies published from 1964 to 2021 from Pubmed and Scopus databases. Data were analysed using Comprehensive Meta-Analysis version 2 and calculated effect sizes were compared between unmedicated and medicated patients with schizophrenia and healthy controls. Heterogeneity, publication bias assessments and subgroup analyses of drug-free and drug-naïve patients, and patients treated with atypical and typical antipsychotics were conducted. Subgroup analysis of confounding factors including age, gender, illness duration and patient status was also conducted. We found that glutathione peroxidase (GPx) was significantly decreased in all patients. Significantly lower catalase (CAT), glutathione (GSH) and albumin (ALB) were found in unmedicated patients only. Both groups showed significantly weakened non-enzymatic antioxidant capacity. Subgroup analyses indicated that weakened non-enzymatic antioxidant capacity may be associated with schizophrenia. Antioxidant status was more impaired in drug-free patients compared with other subgroups. This indicated that antipsychotics may improve antioxidant defense system. Although effect sizes were smaller, future studies may focus on the effect of antipsychotic discontinuation. In overall, schizophrenia was associated with impaired antioxidant defense system especially the non-enzymatic antioxidant system.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In three groups of treated and untreated patients with schizophrenia and healthy controls, GPx was significantly lowered in both groups of patients; untreated patients revealed decreased levels of CAT, GSH, and albumin; both groups showed significantly lowered non-enzymatic antioxidant capacity; antioxidant status was most significantly impaired in untreated patients, confirming level of抗氧化剂 in患者与
“It was found that the enzyme glutathione peroxidase (GPx) was significantly lowered in both groups of patients. Untreated patients revealed decreased levels of catalase (CAT), glutathione (GSH), and albumin. Both groups of patients, treated and untreated showed significantly lowered non-enzymatic antioxidant capacity. Antioxidant status was most significantly impaired in untreated patients, confir”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Goh et al. 2022
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · see citing works
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
Benzie, I. F. F., & Strain, J. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0292 · Cited by 23,027 · see citing works
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · see citing works
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735 · see citing works
Assessing heterogeneity in meta-analysis: Q statistic or I² index?
Huedo-Medina, T. B., Sánchez-Meca, J., Marín-Martínez, F., & Botella, J. (2006) · Psychological Methods · doi:10.1037/1082-989x.11.2.193 · Cited by 4,256 · see citing works
Ighodaro, O. M., & Akinloye, O. A. (2017) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.09.001 · Cited by 4,036 · see citing works
Miller, N. J., Rice-Evans, C. A., Davies, M. J., Gopinathan, V., & Milner, A. D. (1993) · Clinical Science · doi:10.1042/cs0840407 · Cited by 3,108 · see citing works
Erel, Ö. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.11.015 · Cited by 2,940 · see citing works
Gusenbauer, M., & Haddaway, N. R. (2020) · Research Synthesis Methods · doi:10.1002/jrsm.1378 · Cited by 2,379 · see citing works
Free radicals, natural antioxidants, and their reaction mechanisms
Nimse, S. B., & Pal, D. (2015) · RSC Advances · doi:10.1039/c4ra13315c · Cited by 2,084 · see citing works
A novel automated method to measure total antioxidant response against potent free radical reactions
Erel, Ö. (2003) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.10.014 · Cited by 1,771 · see citing works
Publication bias in meta-analysis: Prevention, assessment and adjustments
Viechtbauer, W. (2007) · Psychometrika · doi:10.1007/s11336-006-1450-y · Cited by 1,507 · see citing works
Regulation of uric acid metabolism and excretion
Maiuolo, J., Oppedisano, F., Gratteri, S., Muscoli, C., & Mollace, V. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.109 · Cited by 1,405 · see citing works
Masella, R., Benedetto, R. D., Varı́, R., Filesi, C., & Giovannini, C. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.05.013 · Cited by 1,109 · see citing works
Luchini, C., Stubbs, B., Solmi, M., & Veronese, N. (2017) · World Journal of Meta-Analysis · doi:10.13105/wjma.v5.i4.80 · Cited by 977 · see citing works
Endogenous non-enzymatic antioxidants in the human body
Mirończuk-Chodakowska, I., Witkowska, A. M., & Zujko, M. E. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.05.005 · Cited by 620 · see citing works
Gan, K., Smolen, A., Eckerson, H. W., & Du, B. N. L. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07065-5 · Cited by 596 · see citing works
Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging
Mohanty, J. G., Nagababu, E., & Rifkind, J. M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00084 · Cited by 595 · see citing works
The role of thiols in antioxidant systems
Ulrich, K., & Jakob, U. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.035 · Cited by 561 · see citing works
Meta-analysis of oxidative stress in schizophrenia.
Flatow, J., Buckley, P., & Miller, B. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.018 · Cited by 491 · see citing works
The nature of relapse in schizophrenia
Emsley, R. A., Chiliza, B., Asmal, L., & Harvey, B. H. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-50 · Cited by 481 · see citing works
Specific antioxidant properties of human serum albumin
Taverna, M., Marie, A., Mira, J. P., & Guidet, B. (2013) · Annals of Intensive Care · doi:10.1186/2110-5820-3-4 · Cited by 475 · see citing works
Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma
Janaszewska, A., & Bartosz, G. (2002) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655102317475498 · Cited by 389 · see citing works
Redox dysregulation, neurodevelopment, and schizophrenia
Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.001 · Cited by 384 · see citing works
Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood
Guemouri, L., Artur, Y., Herbeth, B., Jeandel, C., Cuny, G., & Siest, G. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.11.1932 · Cited by 363 · see citing works
Free radical pathology and antioxidant defense in schizophrenia: a review
Mahadik, S. P., & Mukherjee, S. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00049-6 · Cited by 330 · see citing works
Publication Bias: Recognizing the Problem, Understanding Its Origins and Scope, and Preventing Harm
Dickersin, K. (2005) · doi:10.1002/0470870168.ch2 · Cited by 310 · see citing works
Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis
Fraguas, D., Díaz‐Caneja, C. M., Ayora, M., Hernández-Álvarez, F., Rodríguez-Quiroga, A., Recio, S., Leza, J. C., & Arango, C. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby125 · Cited by 272 · see citing works
Oxidative Stress in Schizophrenia
Grabnar, I., Vovk, T., Plesničar, B. K., & Boskovic, M. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596595 · Cited by 250 · see citing works
The paraoxonases: role in human diseases and methodological difficulties in measurement
Camps, J., Marsillach, J., & Joven, J. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360802610878 · Cited by 245 · see citing works
Meta-Analytic Methodology for Basic Research: A Practical Guide
Mikolajewicz, N., & Komarova, S. V. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00203 · Cited by 237 · see citing works
Orlovska‐Waast, S., Köhler‐Forsberg, O., Brix, S. W., Nordentoft, M., Kondziella, D., Krogh, J., & Benros, M. E. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0220-4 · Cited by 233 · see citing works
Parikh, V., Khan, M. M., & Mahadik, S. P. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00048-1 · Cited by 224 · see citing works
Publication bias as a threat to the validity of meta-analytic results
Rothstein, H. R. (2008) · Journal of Experimental Criminology · doi:10.1007/s11292-007-9046-9 · Cited by 216 · see citing works
Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in arteriosclerosis diseases
Garelnabi, M., Litvinov, D. Y., & Mahini, H. (2012) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.103310 · Cited by 211 · see citing works
Oxidative Stress Indexes for Diagnosis of Health or Disease in Humans
Sánchez-Rodrı́guez, M. A., & Mendoza-Núñez, V. M. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4128152 · Cited by 206 · see citing works
Nagababu, E., Chrest, F. J., & Rifkind, J. M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00537-8 · Cited by 198 · see citing works
Non-enzymatic antioxidant capacity assays: Limitations of use in biomedicine
Bartosz, G. (2010) · Free Radical Research · doi:10.3109/10715761003758114 · Cited by 179 · see citing works
A meta-analysis of oxidative stress markers in schizophrenia
Zhang, M., Zhao, Z., He, L., & Wan, C. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0013-8 · Cited by 173 · see citing works
Raffa, M., Mechri, A., Othman, L. B., Fendri, C., Gaha, L., & Kerkeni, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.018 · Cited by 173 · see citing works
Yuan, X., Zhang, P., Wang, Y., Liu, Y., Li, X., Kumar, B. U., Hei, G., Lv, L., Huang, X., Fan, X., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.05.017 · Cited by 160 · see citing works
Systemic Biomarkers of Accelerated Aging in Schizophrenia: A Critical Review and Future Directions
Nguyen, T. T., Eyler, L. T., & Jeste, D. V. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx069 · Cited by 154 · see citing works
Pillai, A., Parikh, V., Terry, A. V., & Mahadik, S. P. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.011 · Cited by 153 · see citing works
Free radicals and tardive dyskinesia
Cadet, J. L., Lohr, J. B., & Jeste, D. V. (1986) · Trends in Neurosciences · doi:10.1016/0166-2236(86)90035-4 · Cited by 147 · see citing works
Cadet, J. L., & Lohr, J. B. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb14918.x · Cited by 135 · see citing works
Haloperidol- and clozapine-induced oxidative stress in the rat brain
Polydoro, M., Schröder, N., de Lima, M. N. M., Caldana, F., Laranja, D. C., Bromberg, E., Roesler, R., Quevedo, J., Moreira, J. C. F., & Dal‐Pizzol, F. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.05.018 · Cited by 134 · see citing works
Nonenzymatic Exogenous and Endogenous Antioxidants
Moussa, Z., Judeh, Z. M. A., & Ahmed, S. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87778 · Cited by 123 · see citing works
Antidepressants- and antipsychotics-induced hepatotoxicity
Todorović, N., Đorđević, J., Pejić, S., Đorđević, N. O., & Pajović, S. B. (2021) · Archives of Toxicology · doi:10.1007/s00204-020-02963-4 · Cited by 119 · see citing works
Gonzalez-Liencres, C., Taş, C., Brown, E. C., Erdin, S., Onur, E., Çubukcoǧlu, Z., Aydemır, Ö., Esen-Danacı, A., & Brüne, M. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0268-x · Cited by 118 · see citing works
Othmen, L. B., Mechri, A., Fendri, C., Bost, M., Chazot, G., Gaha, L., & Kerkeni, A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.003 · Cited by 117 · see citing works
Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain
Reinke, A., Martins, M. R., de Lima, M. S., Moreira, J. C. F., Dal‐Pizzol, F., & Quevedo, J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.032 · Cited by 107 · see citing works
Fraguas, D., Díaz‐Caneja, C. M., Rodríguez-Quiroga, A., & Arango, C. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx015 · Cited by 106 · see citing works
Total Thiols: Biomedical Importance And Their Alteration In Various DisordersPreprint
Prakash, M., Shetty, M. S., Tilak, P., & Anwar, N. (2009) · CogPrints (University of Southampton) · Cited by 104 · see citing works
Fukushima, T., Iizuka, H., Yokota, A., Suzuki, T., Ohno, C., Kono, Y., Nishikiori, M., Seki, A., Ichiba, H., Watanabe, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101652 · Cited by 102 · see citing works
Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
Caruso, G., Grasso, M., Fidilio, A., Tascedda, F., Drago, F., & Caraci, F. (2020) · Pharmaceuticals · doi:10.3390/ph13120457 · Cited by 88 · see citing works
Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
Xiao, M.-W., Lin, S., Shen, Z., Luo, W., & Wang, X. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/1484598 · Cited by 85 · see citing works
Thiols are Main Determinants of Total Antioxidant Capacity of Cellular Homogenates
Balcerczyk, A., & Bartosz, G. (2003) · Free Radical Research · doi:10.1080/1071576031000083189 · Cited by 84 · see citing works
Radonjić, N. V., Knežević, I. D., Vilimanovich, U., Kravić-Stevović, T., Marina, L. V., Nikolić, T., Todorović, V., Bumbaširević, V., & Petronijević, N. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.009 · Cited by 75 · see citing works
Oxidative stress in bipolar and schizophrenia patients
Tunçel, Ö. K., Sarísoy, G., Bilgici, B., Pazvantoğlu, O., Çetin, E., Ünverdi, E., Avcı, B., & Böke, Ö. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.04.046 · Cited by 62 · see citing works
Imbalanced free radicals and antioxidant defense systems in schizophrenia: A comparative study
Li, H.-C., Chen, Q., Ma, Y., & Zhou, J.-F. (2006) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2006.b0981 · Cited by 62 · see citing works
Gysin, R., Kraftsik, R., Boulat, O., Bovet, P., Conus, P., Comte-Krieger, E., Polari, A. R., Steullet, P., Preisig, M., Bellier-Teichmann, T., et al. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3463 · Cited by 62 · see citing works
Park, S. W., Lee, C. H., Lee, J. G., Kim, L. W., Shin, B. S., Lee, B. J., & Kim, Y. H. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.01.004 · Cited by 59 · see citing works
Oxidative stress and neopterin abnormalities in schizophrenia: A longitudinal study
Chittiprol, S., Venkatasubramanian, G., Neelakantachar, N., Babu, S. V. S., Reddy, N. A., Shetty, K. T., & Gangadhar, B. N. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.09.002 · Cited by 57 · see citing works
Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?
Moreira, E. G., Boll, K. M., Correia, D. G., Soares, J. F., Rigobello, C., & Maes, M. H. J. (2018) · Current Neuropharmacology · doi:10.2174/1570159x17666181227164947 · Cited by 57 · see citing works
Stojković, T., Radonjić, N. V., Velimirović, M., Jevtić, G., POPOVIC, V. M., Doknić, M., & Petronijević, N. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.013 · Cited by 53 · see citing works
Ribaudo, G., Bortoli, M., Pavan, C., Zagotto, G., & Orian, L. (2020) · Antioxidants · doi:10.3390/antiox9080714 · Cited by 51 · see citing works
Antipsychotic Medication and Oxidative Cell Stress
Lepping, P., Delieu, J., Mellor, R., Williams, J. H. H., Hudson, P. R., & Hunter-Lavin, C. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05268yel · Cited by 49 · see citing works
Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia
Sadowska‐Bartosz, I., Galiniak, S., Bartosz, G., Żuberek, M., Grzelak, A., & Dietrich‐Muszalska, A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.07.010 · Cited by 48 · see citing works
Quincozes‐Santos, A., Bobermin, L. D., Tonial, R. P. L., Bambini-Júnior, V., Riesgo, R. D. S., & Gottfried, C. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0095-0 · Cited by 42 · see citing works
The genotoxic and oxidative damage potential of olanzapine in vitro
Türkez, H., & Toğar, B. (2010) · Toxicology and Industrial Health · doi:10.1177/0748233710373090 · Cited by 41 · see citing works
Free Radical Medicine and Biology
Das, K. K., Das, S. N., Biradar, M. S., Bobbarala, V., & Tata, S. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77829 · Cited by 32 · see citing works
Harvey, B. H., & Bester, A.-M. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00156-x · Cited by 28 · see citing works
Miljević, Č., Nikolić‐Kokić, A., Nikolic, M. R., Niketić, V., Spasić, M. B., Lečić‐Toševski, D., & Blagojević, D. P. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2272 · Cited by 26 · see citing works
Schmidt, A. J., Hemmeter, U., Krieg, J.-C., Vedder, H., & Heiser, P. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.11.005 · Cited by 22 · see citing works
Risperidone‐Induced Renal Damage and Metabolic Side Effects: The Protective Effect of Resveratrol
Bilğiç, S., Korkmaz, D. T., Azırak, S., Güvenç, A., Kocaman, N., & Özer, M. K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8709521 · Cited by 20 · see citing works
Khalifa, A. E. (2004) · Human & Experimental Toxicology · doi:10.1191/0960327104ht470oa · Cited by 19 · see citing works
Paradis, M., Gagné, J., Mateescu, M., & Paquin, J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.030 · Cited by 16 · see citing works
Oxidative Stress and Schizophrenia
Huang, D., & Liu, S. (2017) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20170006 · Cited by 16 · see citing works
Bryll, A., Krzyściak, W., Karcz, P., Śmierciak, N., Kozicz, T., Skrzypek, J., Szwajca, M., Pilecki, M. W., & Popiela, T. J. (2020) · Biomolecules · doi:10.3390/biom10091272 · Cited by 15 · see citing works
Reyes-Madrigal, F., León-Ortíz, P., Mao, X., Mora-Durán, R., Shungu, D. C., & de la Fuente‐Sandoval, C. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.08.003 · Cited by 14 · see citing works
Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity
Avcıkurt, A. S., Sinan, S., & KOCKAR, F. T. (2014) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.913038 · Cited by 12 · see citing works
Abdel‐Salam, O. M. E., El-Shamarka, M. E.-S., & Omara, E. A. A. (2018) · doi:10.20455/ros.2018.839 · Cited by 12 · see citing works
Fathy, H., Bayoumy, H. A. H., Mawella, S. M. A., Gomaa, M. A., & Al-Hanafi, H. (2015) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000471347.83522.d8 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638 · see citing works
De Simone, G., Mazza, B., Vellucci, L., Barone, A., Ciccarelli, M., & de Bartolomeis, A. (2023) · Antioxidants · doi:10.3390/antiox12040975 · Cited by 49 · see citing works
Yang, M., Wang, C., Zhao, G., Kong, D., Liu, L., Yuan, S., Chen, W., Feng, C., & Li, Z. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220706101021 · Cited by 30 · see citing works
Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome
Khasanova, A. K., Добродеева, В. С., Shnayder, N. A., Петрова, М. М., Пронина, Е., Николаевна, Б. Е., Ларева, Н. В., Garganeeva, N. P., Smirnova, D. A., & Nasyrova, R. F. (2022) · Metabolites · doi:10.3390/metabo12080726 · Cited by 23 · see citing works
Frota, I. J., de Oliveira, A. L. B., de Lima, D. N., Filho, C. W. L. C., Menezes, C. E. D. S., Soares, M. V. R., Filho, A. J. M. C., Lós, D. B., Moreira, R. T. D. A., Viana, G. D. A., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05050-x · Cited by 20 · see citing works
Liu, F., Bai, Q., Tang, W., Zhang, S., Guo, Y. H., Pan, S., Ma, X., Yang, Y., & Fan, H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1505153 · Cited by 19 · see citing works
Zhang, K., Zou, L., & Cai, Y. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1505397 · Cited by 14 · see citing works
Transforming Healthcare with Nanomedicine: A SWOT Analysis of Drug Delivery Innovation
Zhang, H., Li, S., & Ma, X. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s470210 · Cited by 16 · see citing works
Lin, C., Li, T., Huang, Y.-J., Chen, S.-J., & Lane, H. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad040 · Cited by 12 · see citing works
Giongo, F. K., Gallas‐Lopes, M., Benvenutti, R., Sachett, A., Bastos, L. M., Rosa, A. R., & Herrmann, A. P. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac073 · Cited by 9 · see citing works
Li, L., Du, F., Liu, X., Song, M., Grosso, G., Battino, M., Boesch, C., Li, H., & Liu, X. (2025) · Foods · doi:10.3390/foods14101773 · Cited by 6 · see citing works
“Antipsychotic drugs can relieve this symptom; however, they contribute to some side effects [55].”
Isomura, Y., Ohno, M., Sudo, S., Ono, M., Kaminishi, Y., Sumi, Y., Yoshimura, A., Fujii, K., Akiyama, K., Nishi, E., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30193 · Cited by 4 · see citing works
Lin, C., & Lane, H. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.11.010 · Cited by 2 · see citing works
Lin, C., Zhang, S., Yang, P., Zhang, B., Guo, W., Wu, R., Liu, Y., Wang, J., Wu, H., & Cai, H. (2024) · Schizophrenia · doi:10.1038/s41537-024-00473-1 · Cited by 2 · see citing works
Hyperhomocysteinemia in Treatment with Atypical Antipsychotics is Independent of Metabolic Syndrome
Sarandöl, E., Demirci, M., Sarandöl, A., & Sürmen-Gür, E. (2023) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.1218802 · Cited by 1 · see citing works
The role of 5-HT3 receptors in schizophrenia and associated depressive and addictive comorbidities
Jůza, R., Więckowska, A., Vojtěchová, I., Kuča, K., Soukup, O., Korábečný, J., & Petrásek, T. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111663 · Cited by 1 · see citing works
Spasic, D. M., Spasić, S. D., Nikolić‐Kokić, A., & Miljević, Č. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167105 · Cited by 1 · see citing works
Mayén-Lobo, Y. G., Alcaraz-Zubeldia, M., de Montellano, D. J. D., Motilla-Frías, B. A., García-Manteca, M. Y., Ortega‐Vázquez, A., Aviña-Cervantes, C. L., Crail‐Meléndez, D., Rı́os, C., López, M., et al. (2022) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2022-2783 · Cited by 1 · see citing works
Salgado, J. V., Cruz, B. F., Mantovani, L. M., & Massuda, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-43356-6_13 · Cited by 1 · see citing works
Romash, I. R., Romash, I. B., & Pustovoyt, M. M. (2024) · Wiadomości Lekarskie · doi:10.36740/wlek202407102 · Cited by 1 · see citing works
Fagbomedo, O. F., Saliu, J. A., Omoboyowa, D. A., & Agesin, A. M. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100227
Zhang, C., Wu, Z., Jiang, N., Song, Y., Geng, W., Liu, H., Jin, M., Wang, S., Zhang, J., & Yang, Y. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111476
Du, B., Ma, J., Chen, H., Zhang, K., Wang, Z., Zhao, Z., Li, H., Meng, X., & Liu, Z. (2026) · Annals of General Psychiatry · doi:10.1186/s12991-026-00628-7
Hydrogen Gas Therapy in Schizophrenia: Potential Neuroprotective Effects From an Animal Study
Miyake, N., Haga, T., Hirano, S., Ichikawa, Y., Oguchi, Y., & Ando, K. (2026) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70117
Hydrogen Peroxide Dismutation by Immunoglobulins G from Patients with Schizophrenia
Kazantseva, D. V., Smirnova, L. P., Kornetova, E. G., & Ivanova, S. A. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297926600456
- Authors
- Goh, X. X., Tang, P. Y., & Tee, S. F.
- Affiliations
- Universiti Tunku Abdul Rahman Sungai Long Campus (MY)
- Corresponding author
- Tee, Shiau Foon
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 309
- Pages
- 114429
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W4213100652
- Cited by
- 25
- References
- 83
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 4
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Psychiatry Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- schizophrenia, antipsychotic drugs, antioxidant defense, oxidative stress, glutathione peroxidase, catalase, glutathione, albumin, atypical antipsychotics, typical antipsychotics, unmedicated patients, drug-naive patients
- MeSH terms
- Antioxidants, Glutathione, Glutathione Peroxidase, Humans, Schizophrenia, Antipsychotic Agents, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review